Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis Article

Rangnekar, Bhamini, Momin, Mohammad AM, Eedara, Basanth Babu et al. (2019). Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis . International Journal of Pharmaceutics, 570 10.1016/j.ijpharm.2019.118689

International Collaboration

cited authors

  • Rangnekar, Bhamini; Momin, Mohammad AM; Eedara, Basanth Babu; Sinha, Shubhra; Das, Shyamal C

sustainable development goals

authors

publication date

  • October 30, 2019

published in

keywords

  • AEROSOLIZATION
  • Bedaquiline
  • FORMULATION
  • Formulation
  • IMPROVE
  • IN-VITRO
  • Inhalation
  • L-LEUCINE
  • LARGE POROUS PARTICLES
  • Life Sciences & Biomedicine
  • MOXIFLOXACIN
  • Moxifloxacin
  • PHARMACOKINETICS
  • PYRAZINAMIDE
  • Pharmacology & Pharmacy
  • Pyrazinamide
  • Science & Technology
  • TMC207
  • Tuberculosis

Digital Object Identifier (DOI)

volume

  • 570